| European Case Law Identifier: | ECLI:EP:BA:1999:T027795.19990416 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 16 April 1999 | ||||||||
| Case number: | T 0277/95 | ||||||||
| Application number: | 90118215.4 | ||||||||
| IPC class: | C12N 15/16 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Method for the production of erythropoietin | ||||||||
| Applicant name: | GENETICS INSTITUTE, INC. | ||||||||
| Opponent name: | JANSSEN-CILAG GmbH AMGEN INC. HOECHST AG |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Main request - broadening of scope of claims (no) Added subject-matter (no) Clarity (yes) Right to priority (denied) Novelty (yes) Inventive step (yes) Sufficiency of disclosure (yes) |
||||||||
| Catchwords: |
"Inherency" has to be established on the basis of certainty, not probability or possibility (cf point 15 of the reasons). |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t950277eu1.html
Date retrieved: 17 May 2021
9 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.Case Law Book: II Conditions to be met by an Application
XCLR II D 3.1.5.B Example cases – features of the invention not all disclosed in the priority document
